SEASONAL ALLERGIC RHINITIS
Clinical trials for SEASONAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new SEASONAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for SEASONAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New allergy shot shows promise in early trial
Symptom relief CompletedThis Phase 2 trial tested an injection called TQC2938, a humanized monoclonal antibody, in 136 adults with seasonal allergic rhinitis. All participants also used a standard nasal spray. The study measured how well the injection reduced nasal symptoms like sneezing and congestion …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New hope for cedar fever sufferers: drug eases severe allergy symptoms
Symptom relief CompletedThis study tested a drug called omalizumab in 337 adults and teens with severe Japanese cedar pollen allergy (hay fever) that standard medicines couldn't control. Participants received either omalizumab or a placebo on top of their usual allergy treatments for 12 weeks. The goal …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New allergy shot shows promise for those failed by standard meds
Symptom relief CompletedThis study tested a new drug called LP-003 in 180 adults with moderate to severe seasonal allergic rhinitis (hay fever) that wasn't well controlled by usual treatments like antihistamines or nasal sprays. LP-003 is an antibody that blocks IgE, a key driver of allergic reactions, …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New allergy drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested a single dose of the investigational drug MT-2990 in 75 adults with seasonal allergic rhinitis triggered by Japanese cedar pollen. The main goals were to check the drug's safety, how the body processes it, and whether it can reduce allergy symptoms w…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Early allergy pill may stop sneezing before it starts
Symptom relief CompletedThis study tested whether taking the allergy drug fexofenadine for two days before ragweed season can reduce symptoms like sneezing and runny nose. 95 adults with ragweed allergies were randomly given either fexofenadine or a placebo. Researchers measured nasal symptoms over six …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Symptom relief
Last updated Jun 26, 2026 15:14 UTC